AG regimen (Adriamycin/doxorubicin + gemcitabine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AG regimen (Adriamycin/doxorubicin + gemcitabine), covering 2025-11-17 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy and Immunogenicity of a Tumor Vaccine Injection Targeting Stressinducible Proteins MICA/B in Combination With the AG Regimen in Patients With Metastatic Pancreatic Cancer [EARLY_Phase 1]